Phosphorylated S6 Kinase-1 as Predictive Marker of Lapatinib Efficacy in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients

Eun-Byeol KO; Min-Ki SEONG; Hyang-Suk CHOI; Chan-Sub PARK; Ji-Hye CHOI; Jin-Kyung LEE; Hyesil SEOL; Hyun-Ah KIM; Woo-Chul NOH.
Journal of Breast Disease ; (2): 57-63, 2017.
Artículo en Inglés | WPRIM | ID: wpr-652800

Documentos relacionados

  1. Ribosomal S6 kinases determine intrinsic axonal regeneration capacity.
  2. Mechanistic Target of Rapamycin Complex 1/S6 Kinase 1 Signals Influence T Cell Activation Independently of Ribosomal Protein S6 Phosphorylation.
  3. Role of extracellular electrolytes in the activation of ribosomal protein S6 kinase by epidermal growth factor, insulin-like growth factor 1, and insulin in ZR-75-1 cells.
  4. Plakophilin 3 phosphorylation by ribosomal S6 kinases supports desmosome assembly.
  5. IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils.
  6. GAREM1 is involved in controlling body mass in mice and humans.
  7. PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles.
  8. Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signaling for cell proliferation.
  9. ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer.
  10. Attenuation of ribosomal protein S6 phosphatase activity in chicken embryo fibroblasts transformed by Rous sarcoma virus.